A new initiative from the Department of Medicine at Mass General, the Pathways Service provides a way for medical residents to discuss unusual patient cases and initiate research projects based on the questions the cases raise.
After CAR-T cell immunotherapy’s early successes, Mass General researchers are determined to find out whether it can be used to treat a broad array of cancers and other diseases.
Mass General President Peter L. Slavin, MD, says that, as an organization committed to heal, prevent injuries and promote good health, Mass General should be part of the national dialogue on the national epidemic of gun violence.
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Families whose loved ones have type 1 diabetes are stepping up to support Mass General researcher Denise Faustman, MD, PhD, who has found a potential breakthrough, now being tested in a clinical trial.
Excitement is growing for the promising potential of CAR-T cell immunotherapy, which was used to treat Harrison Morrow’s relapsing multiple myeloma.
A Mass General researcher who spent years studying how infectious diseases develop is using his expertise to develop a new approach to treating certain cancers.
The Dauten Family Center for Bipolar Treatment Innovation at Mass General seeks to advance treatment by creating a global epicenter for research, education and outreach.
Brain imaging data shows that regularly practicing meditation can reduce activity in the part of the brain involved with stress and anxiety in as little as eight weeks.
Elsie Taveras, MD, MPH, uses clinical and community-based research to address the causes of childhood health problems and reduce health disparities.